Niger vs Paraguay: Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and
Niger
18.7%
in 2021
Paraguay
18.6%
in 2021
Niger rank
113th
Paraguay rank
115th
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and over time
- Niger
- Paraguay
How they compare
Niger currently reports 18.7% against 18.6% in Paraguay, a difference of 0.1%.
The two have swapped places 2 times across 22 shared years of data; in 2000 it was Niger ahead.
Niger ranks 113th and Paraguay ranks 115th of 185 countries.
Niger has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Niger | Paraguay | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 19.9% | 19.3% | 0.6% | Niger |
| 2010s | 20.2% | 19.3% | 0.9% | Niger |
| 2020s | 19.4% | 18.4% | 1.0% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher mortality from cvd, cancer, diabetes or crd between exact ages 30 and, Niger or Paraguay?
- Niger, at 18.7% against 18.6% in Paraguay as of 2021.
- What is the difference in mortality from cvd, cancer, diabetes or crd between exact ages 30 and between Niger and Paraguay?
- 0.1%, with Niger ahead.
- How many years of comparable data are there for Niger and Paraguay?
- 22 years are reported by both, from 2000 to 2021.
- How do Niger and Paraguay rank globally for mortality from cvd, cancer, diabetes or crd between exact ages 30 and?
- Niger ranks 113th and Paraguay ranks 115th of 185 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO), published as Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).